Trial Profile
Treatment of Chronic Idiopathic Cough (CIC) and Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF) with PA101
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Sep 2017
Price :
$35
*
At a glance
- Drugs Sodium cromoglicate (Primary)
- Indications Cough
- Focus Proof of concept; Therapeutic Use
- Sponsors Patara Pharma
- 21 Sep 2017 According to a Patara Pharma media release, data were published in The Lancet Respiratory Medicine.
- 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society
- 07 Sep 2016 Primary endpoint has been met. (cough frequency), as reported by a Patara Pharma media release.